Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database
Qiaoling Pan, Hang Chen, Hanbo Pan, Zeyang Hu, Keyue Qiu, Jiaheng Zhang, Ni Li, Yinyu Mu, Keyun Zhu, Guodong Xu, Yiming Shen · 2026
Read Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database by Qiaoling Pan, Hang Chen, Hanbo Pan, Zeyang Hu, Keyue Qiu, Jiaheng Zhang, Ni Li, Yinyu Mu, Keyun Zhu, Guodong Xu, Yiming Shen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13196928.txt.
Description
Qiaoling Pan leads a large team in mining a drug harm report base for risks after lung surgery. The paper is from two thousand twenty-six. Breath shortness, cough, heart flutter, and chest pain dog many patients after such surgery and slow their heal. Which drugs feed those ills was murky.
They use ratio tests to rank the drugs most tied to each of the four signs. A small set earns a high signal mark, and a mid set joins it. Three of the high set are drugs for lung artery hypertension. A deeper read pins the link on the drug class trait itself. The list can guide drug picks after lung surgery.
Catalog record
| CREATOR | Qiaoling Pan, Hang Chen, Hanbo Pan, Zeyang Hu, Keyue Qiu, Jiaheng Zhang, Ni Li, Yinyu Mu, Keyun Zhu, Guodong Xu, Yiming Shen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |